Xellia is a leading producer and marketeer of fermented anti-infective APIs and injectable finished products. We are committed to seamlessly integrate ou

Xellia Pharmaceuticals is a leading developer, manufacturer and supplier of...
See More life-saving anti-infectives. We are a specialty pharmaceutical company focused on fermented antibiotics and injectable finished products. Our products are sold in more than 70 countries to more than 700 customers across the healthcare industry.

In May 2013, Novo A/S acquired the majority stake in Xellia Pharmaceuticals. Novo's expertise in the life sciences sector and long term ownership model will help Xellia accellerate investments in product development and innovation as well as establish high quality manufacturing assets that can support sustainable future growth. Xellia’s growth strategy is rooted in its leading product development competences, extensive manufacturing expertise and strong commercial partnerships.